Urinary Apolipoprotein M as a Biomarker of Acute Kidney Injury in Children Undergoing Heart Surgery

References

• Xu N , DahlbackB. A novel human apolipoprotein (apoM). J. Biol. Chem.274(44), 31286–31290 (1999).
   PubMed Web of Science ®Google Scholar
• Duan J , DahlbackB, VilloutreixBO. Proposed lipocalin fold for apolipoprotein M based on bioinformatics and site-directed mutagenesis. FEBS Lett.499(1–2), 127–132 (2001).
   PubMed Web of Science ®Google Scholar
• Wolfrum C , PoyMN, StoffelM. Apolipoprotein M is required for prebeta-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis. Nat. Med.11(4), 418–422 (2005).
   PubMed Web of Science ®Google Scholar
• Christoffersen C , NielsenLB, AxlerOet al. Isolation and characterization of human apolipoprotein M-containing lipoproteins. J. Lipid Res.47(8), 1833–1843 (2006).
   PubMed Web of Science ®Google Scholar
• Christoffersen C , JauhiainenM, MoserMet al. Effect of apolipoprotein M on high density lipoprotein metabolism and atherosclerosis in low density lipoprotein receptor knock-out mice. J. Biol. Chem.283(4), 1839–1847 (2008).
   PubMed Web of Science ®Google Scholar
• Feingold KR , ShigenagaJK, ChuiLGet al. Infection and inflammation decrease apolipoprotein M expression. Atherosclerosis199(1), 19–26 (2008).
   PubMed Web of Science ®Google Scholar
• Christoffersen C , ObinataH, KumaraswamySBet al. Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M. Proc. Natl Acad. Sci. USA108(23), 9613–9618 (2011).
   PubMed Web of Science ®Google Scholar
• Zhang XY , DongX, ZhengLet al. Specific tissue expression and cellular localization of human apolipoprotein M as determined by in situ hybridization. Acta Histochem.105(1), 67–72 (2003).
   PubMed Web of Science ®Google Scholar
• Axler O , AhnstromJ, DahlbackB. Apolipoprotein M associates to lipoproteins through its retained signal peptide. FEBS Lett.582(5), 826–828 (2008).
   PubMed Web of Science ®Google Scholar
• Christoffersen C , AhnstromJ, AxlerOet al. The signal peptide anchors apolipoprotein M in plasma lipoproteins and prevents rapid clearance of apolipoprotein M from plasma. J. Biol. Chem.283(27), 18765–18772 (2008).
   PubMed Web of Science ®Google Scholar
• Kontush A , ChapmanMJ. Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis. Pharmacol. Rev.58(3), 342–374 (2006).
   PubMed Web of Science ®Google Scholar
• Faber K , HvidbergV, MoestrupSK, DahlbackB, NielsenLB. Megalin is a receptor for apolipoprotein M, and kidney-specific megalin-deficiency confers urinary excretion of apolipoprotein M. Mol. Endocrinol.20(1), 212–218 (2006).
   PubMedGoogle Scholar
• Uchino S , BellomoR, BagshawSM, GoldsmithD. Transient azotaemia is associated with a high risk of death in hospitalized patients. Nephrol. Dial. Transplant.25(6), 1833–1839 (2010).
   PubMed Web of Science ®Google Scholar
• Rosner MH , OkusaMD. A cute kidney injury associated with cardiac surgery. Clin. J. Am. Soc. Nephrol.1(1), 19–32 (2006).
   PubMed Web of Science ®Google Scholar
• Coppolino G , PrestaP, SaturnoL, FuianoG. Acute kidney injury in patients undergoing cardiac surgery. J. Nephrol.26(1), 32–40 (2013).
   PubMed Web of Science ®Google Scholar
• Pedersen KR , RavnHB, PovlsenJVet al. Failure of remote ischemic preconditioning to reduce the risk of postoperative acute kidney injury in children undergoing operation for complex congenital heart disease: a randomized single-center study. J. Thorac. Cardiovasc. Surg.143(3), 576–583 (2012).
   PubMed Web of Science ®Google Scholar
• Toth R , BreuerT, CserepZet al. Acute kidney injury is associated with higher morbidity and resource utilization in pediatric patients undergoing heart surgery. Ann. Thorac. Surg.93(6), 1984–1990 (2012).
   PubMed Web of Science ®Google Scholar
• Hassinger AB , BackerCL, LaneJCet al. Predictive power of serum cystatin C to detect acute kidney injury and pediatric-modified RIFLE class in children undergoing cardiac surgery*. Pediatr. Crit Care Med.13(4), 435–440 (2012).
   PubMed Web of Science ®Google Scholar
• Morgan CJ , ZappitelliM, RobertsonCMet al. Risk factors for and outcomes of acute kidney injury in neonates undergoing complex cardiac surgery. J. Pediatr.162(1), 120–127 (2013).
   PubMed Web of Science ®Google Scholar
• Ricci Z , NettoR, GaristoCet al. Whole blood assessment of neutrophil gelatinase-associated lipocalin versus pediatricRIFLE for acute kidney injury diagnosis and prognosis after pediatric cardiac surgery: cross-sectional study. Pediatr. Crit Care Med.2012(13), 667–670 (2012).
   Google Scholar
• Bellomo R , RoncoC, KellumJA, MehtaRL, PalevskyP. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit. Care8(4), R204–R212 (2004).
   PubMed Web of Science ®Google Scholar
• Mehta RL , KellumJA, ShahSVet al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit. Care11(2), R31 (2007).
   PubMed Web of Science ®Google Scholar
• Akcan-Arikan A , ZappitelliM, LoftisLLet al. Modified RIFLE criteria in critically ill children with acute kidney injury. Kidney Int.71(10), 1028–1035 (2007).
   PubMed Web of Science ®Google Scholar
• de Geus HR , BetjesMG, BakkerJ. Biomarkers for the prediction of acute kidney injury: a narrative review on current status and future challenges. Clin. Kidney J.5(2), 102–108 (2012).
   PubMedGoogle Scholar
• KDIGO (Kidney Disease Improving Global Outcome) . Section 2: AKI Definition. Kidney Int. Suppl.2, 19–36 (2012).
   Google Scholar
• Slagman MC , WaandersF, HemmelderMHet al. Moderate dietary sodium restriction added to angiotensin converting enzyme inhibition compared with dual blockade in lowering proteinuria and blood pressure: randomised controlled trial. BMJ343, d4366 (2011).
   PubMed Web of Science ®Google Scholar
• Axler O , AhnstromJ, DahlbackB. An ELISA for apolipoprotein M reveals a strong correlation to total cholesterol in human plasma. J. Lipid Res.48(8), 1772–1780 (2007).
   PubMed Web of Science ®Google Scholar
• ExPASy Bioinformatics Resource Panel. Compute pI/Mw tool. http://web.expasy.org/compute_pi/.
   Google Scholar
• Kumaraswamy SB , LinderA, AkessonP, DahlbackB. Decreased plasma concentrations of apolipoprotein M in sepsis and systemic inflammatory response syndromes. Crit. Care16(2), R60 (2012).
   PubMed Web of Science ®Google Scholar
• Soni SS , RoncoC, KatzN, CruzDN. Early diagnosis of acute kidney injury: the promise of novel biomarkers. Blood Purif.28(3), 165–174 (2009).
   PubMed Web of Science ®Google Scholar
• Borregaard N , SehestedM, NielsenBS, SengelovH, KjeldsenL. Biosynthesis of granule proteins in normal human bone marrow cells. Gelatinase is a marker of terminal neutrophil differentiation. Blood85(3), 812–817 (1995).
   PubMed Web of Science ®Google Scholar
• Seveus L , AminK, PetersonCG, RoomansGM, VengeP. Human neutrophil lipocalin (HNL) is a specific granule constituent of the neutrophil granulocyte. Studies in bronchial and lung parenchymal tissue and peripheral blood cells. Histochem. Cell Biol.107(5), 423–432 (1997).
   PubMed Web of Science ®Google Scholar
• Friedl A , StoeszSP, BuckleyP, GouldMN. Neutrophil gelatinase-associated lipocalin in normal and neoplastic human tissues. Cell type-specific pattern of expression. Histochem. J.31(7), 433–441 (1999).
   PubMedGoogle Scholar
• Cowland JB , BorregaardN. Molecular characterization and pattern of tissue expression of the gene for neutrophil gelatinase-associated lipocalin from humans. Genomics45(1), 17–23 (1997).
   PubMed Web of Science ®Google Scholar
• Goetz DH , HolmesMA, BorregaardNet al. The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. Mol. Cell10(5), 1033–1043 (2002).
   PubMed Web of Science ®Google Scholar
• Mori K , LeeHT, RapoportDet al. Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J. Clin. Invest115(3), 610–621 (2005).
   PubMed Web of Science ®Google Scholar
• Mishra J , MoriK, MaQet al. Amelioration of ischemic acute renal injury by neutrophil gelatinase-associated lipocalin. J. Am. Soc. Nephrol.15(12), 3073–3082 (2004).
   PubMed Web of Science ®Google Scholar
• Mishra J , MaQ, PradaAet al. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J. Am. Soc. Nephrol.14(10), 2534–2543 (2003).
   PubMed Web of Science ®Google Scholar
• Haase M , BellomoR, DevarajanP, SchlattmannP, Haase-FielitzA. Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am. J. Kidney Dis.54(6), 1012–1024 (2009).
   PubMed Web of Science ®Google Scholar
• Mishra J , DentC, TarabishiRet al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet365(9466), 1231–1238 (2005).
   PubMed Web of Science ®Google Scholar
• Cai L , RubinJ, HanW, VengeP, XuS. The origin of multiple molecular forms in urine of HNL/NGAL. Clin. J. Am. Soc. Nephrol.5(12), 2229–2235 (2010).
   PubMed Web of Science ®Google Scholar
• Martensson J , XuS, BellM, MartlingCR, VengeP. Immunoassays distinguishing between HNL/NGAL released in urine from kidney epithelial cells and neutrophils. Clin. Chim. Acta413(19–20), 1661–1667 (2012).
   PubMed Web of Science ®Google Scholar
• Bolignano D , CoppolinoG, CampoSet al. Urinary neutrophil gelatinase-associated lipocalin (NGAL) is associated with severity of renal disease in proteinuric patients. Nephrol. Dial. Transplant.23(1), 414–416 (2008).
   PubMed Web of Science ®Google Scholar
• Bolignano D , CoppolinoG, AloisiCet al. Effect of a single intravenous immunoglobulin infusion on neutrophil gelatinase-associated lipocalin levels in proteinuric patients with normal renal function. J. Investig. Med.56(8), 997–1003 (2008).
   PubMed Web of Science ®Google Scholar
• Awad AS , YeH, HuangLet al. Selective sphingosine 1-phosphate 1 receptor activation reduces ischemia-reperfusion injury in mouse kidney. Am. J. Physiol Renal Physiol290(6), F1516–F1524 (2006).
   PubMed Web of Science ®Google Scholar
• Lien YH , YongKC, ChoC, IgarashiS, LaiLW. S1P(1)-selective agonist, SEW2871, ameliorates ischemic acute renal failure. Kidney Int.69(9), 1601–1608 (2006).
   PubMed Web of Science ®Google Scholar